PetMed Express, Inc. (NASDAQ:PETS) issued its quarterly earnings results on Monday. The company reported $0.43 earnings per share for the quarter, topping analysts’ consensus estimates of $0.30 by $0.13, Bloomberg Earnings reports. The company had revenue of $66.70 million during the quarter, compared to analyst estimates of $63.41 million. PetMed Express had a net margin of 10.34% and a return on equity of 28.67%. The business’s revenue for the quarter was up 9.7% compared to the same quarter last year. During the same period in the prior year, the business posted $0.24 EPS.

PetMed Express (PETS) traded up 20.17% during mid-day trading on Monday, reaching $44.15. 3,702,790 shares of the company traded hands. The firm has a market cap of $895.89 million, a PE ratio of 33.96 and a beta of 1.03. PetMed Express has a one year low of $18.90 and a one year high of $50.90. The stock’s 50-day moving average price is $35.65 and its 200-day moving average price is $35.91.

In other news, Director Ronald J. Korn sold 5,000 shares of the firm’s stock in a transaction dated Friday, July 28th. The shares were sold at an average price of $48.18, for a total value of $240,900.00. Following the transaction, the director now owns 67,333 shares of the company’s stock, valued at approximately $3,244,103.94. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Bruce S. Rosenbloom sold 6,833 shares of the firm’s stock in a transaction dated Thursday, July 27th. The shares were sold at an average price of $50.18, for a total transaction of $342,879.94. Following the completion of the transaction, the chief financial officer now directly owns 18,534 shares in the company, valued at approximately $930,036.12. The disclosure for this sale can be found here. Insiders sold a total of 19,333 shares of company stock worth $949,730 in the last ninety days. Insiders own 4.00% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “PetMed Express, Inc. (PETS) Posts Earnings Results, Beats Expectations By $0.13 EPS” was first posted by American Banking News and is owned by of American Banking News. If you are reading this article on another publication, it was illegally copied and reposted in violation of US & international copyright laws. The original version of this article can be viewed at https://www.americanbankingnews.com/2017/10/23/petmed-express-inc-pets-posts-earnings-results-beats-expectations-by-0-13-eps.html.

A number of brokerages have recently weighed in on PETS. Noble Financial reaffirmed a “hold” rating on shares of PetMed Express in a research note on Wednesday, July 26th. Craig Hallum reissued a “hold” rating and set a $40.00 target price (down from $43.00) on shares of PetMed Express in a research note on Monday, August 21st. They noted that the move was a valuation call. BidaskClub lowered shares of PetMed Express from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, August 22nd. Northcoast Research raised shares of PetMed Express from a “neutral” rating to a “buy” rating and set a $54.00 target price for the company in a research note on Monday, July 24th. Finally, Sidoti raised shares of PetMed Express from a “neutral” rating to a “buy” rating and set a $47.00 target price for the company in a research note on Thursday, August 24th. One analyst has rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the stock. PetMed Express has a consensus rating of “Hold” and an average price target of $40.00.

About PetMed Express

PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.

Earnings History for PetMed Express (NASDAQ:PETS)

Receive News & Ratings for PetMed Express Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express Inc. and related companies with MarketBeat.com's FREE daily email newsletter.